• Nenhum resultado encontrado

Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction.

N/A
N/A
Protected

Academic year: 2017

Share "Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction."

Copied!
9
0
0

Texto

Loading

Imagem

Figure 1 shows that among prostate cancer cases there was a shorter waiting time-to-onset in IL6R Asp358Ala C-allele carriers (P = 0.026) and in IGF1R+ 3174 AA homozygous (P = 0.002)
Table 3. Tertiles of inclusive genetic risk score (GRS) and age-adjusted OR (CI 95%) for prostate cancer.

Referências

Documentos relacionados

capable of stratifying patients into three different levels of risk of death from coronary artery bypass graft surgery: low risk (score < 3), intermediate risk (score 3

Based on these association results, the sum score of SNPs showing the most significant effects (i.e. the number of risk alleles over all SNPs) weighted by the ln(OR) of these

Patients with a score of zero to five were considered as being low risk; from six to nine, as moderate risk and a score higher than 10 as high risk for cardiac,

High-risk prostate cancer includes advanced clinical stage (> T2), Gleason score 8-10 or PSA level > 20ng/mL.. Men with high-risk prostate cancer experience

However, according to the Global Risk Score, 18% of the participants were low risk, 45% were intermediate risk and 37% were high risk for infarction or death from coronary

(36) calculated a genetic risk score based on 13 SNPs and observed an association with a first coronary heart disease event, but the genetic risk score did not improve risk

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta- analysis.. Cancer